The effect of topical betametazon versus topical tacrolimus 0.1% in the treatment of vitiligo
Phase 3
- Conditions
- Vitiligo.Vitiligo
- Registration Number
- IRCT201311295605N6
- Lead Sponsor
- Tabriz university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with vitiligo over 2 years old and less than 30% of body surface area involved.
Exclusion criteria: Patients with allergy or hypersensitivity to macrolides; Pregnant and lactating women; Patients with immune deficiency and patients who had received vitiligo medications less than 6 months ago
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of vitiligo skin lesion. Timepoint: 6 month. Method of measurement: Clinical assesment.
- Secondary Outcome Measures
Name Time Method